Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Chubb
Argus Health
Harvard Business School
Boehringer Ingelheim
Covington
Express Scripts
Deloitte
Farmers Insurance

Generated: April 19, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 074118

« Back to Dashboard

NDA 074118 describes PIROXICAM, which is a drug marketed by Cycle Pharms Ltd, Egis, Flamingo Pharms, Hikma Pharms, Ivax Sub Teva Pharms, Laboratorios Cinfa, Micro Labs, Mylan, Mylan Ireland Ltd, PII, SCS, Strides Pharma, Sun Pharm Industries, Teva, Teva Pharms, Unichem Labs Ltd, and Watson Labs, and is included in twenty-two NDAs. It is available from twenty-four suppliers. Additional details are available on the PIROXICAM profile page.

The generic ingredient in PIROXICAM is piroxicam. There are sixteen drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the piroxicam profile page.
Summary for 074118
Tradename:PIROXICAM
Applicant:Mylan Ireland Ltd
Ingredient:piroxicam
Patents:0
Therapeutic Class:Analgesics
Anti-inflammatory Agents
Formulation / Manufacturing:see details
Pharmacology for NDA: 074118
Medical Subject Heading (MeSH) Categories for 074118
Suppliers and Packaging for NDA: 074118
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
PIROXICAM piroxicam CAPSULE;ORAL 074118 ANDA Mylan Pharmaceuticals Inc. 0378-0467 N 0378-0467-05
PIROXICAM piroxicam CAPSULE;ORAL 074118 ANDA Mylan Pharmaceuticals Inc. 0378-0467 N 0378-0467-01

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE;ORALStrength20MG
Approval Date:Jun 15, 1993TE:ABRLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Moodys
Fuji
Cerilliant
Julphar
US Army
Teva
Cipla
Citi
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.